Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/16/2017 11/17/2017 11/20/2017 11/21/2017 11/22/2017 Date
208.51(c) 209.02(c) 210.67(c) 212.05(c) 215.35(c) Last
563 729 545 558 585 423 503 191 692 166 Volume
+1.50% +0.24% +0.79% +0.66% +1.56% Change
More quotes
Financials ($)
Sales 2017 2 709 M
EBIT 2017 652 M
Net income 2017 812 M
Finance 2017 805 M
Yield 2017 -
Sales 2018 3 072 M
EBIT 2018 820 M
Net income 2018 616 M
Finance 2018 1 143 M
Yield 2018 -
P/E ratio 2017 39,00
P/E ratio 2018 51,85
EV / Sales2017 11,3x
EV / Sales2018 9,86x
Capitalization 31 441 M
More Financials
Company
Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function.It provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing services.The company... 
More about the company
Surperformance© ratings of Illumina
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA
11/22 ILLUMINA : to Webcast Upcoming Investor Conference Presentation
11/22 Illumina Wins UK Patent Suit Against Premaitha Health, Ariosa Diagnostics
11/21 ILLUMINA : Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagno..
11/21 ILLUMINA : Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550D..
11/21 ILLUMINA : Patent Issued for Confocal Imaging Methods and Apparatus (USPTO 98169..
11/21 ILLUMINA : Patent Issued for Methods for Sequencing Polynucleotides (USPTO 98161..
11/16 ILLUMINA INC : Change in Directors or Principal Officers (form 8-K)
11/15 ILLUMINA : Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550D..
11/09 ILLUMINA, INC. (NASDAQ : ILMN) Files An 8-K Departure of Directors or Certain Of..
11/08 ILLUMINA INC : Change in Directors or Principal Officers (form 8-K)
More news
Sector news : Advanced Medical Equipment & Technology - NEC
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/12 FISHER & PAYKEL HEALTHCARE : & Paykel says UK court rules rival Resmed's patent ..
10/30DJROYAL PHILIPS : Correction to Philips Share Buyback Article
10/30DJROYAL PHILIPS : Philips Launches EUR150 Million Share Buyback for Employee Stock..
10/23 European stocks hold firm as banks, Spanish shares fall
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on ILLUMINA 
ILLUMINA - 10/06
There is still some upside potential
BUY
ILLUMINA - 06/29
The stock is approaching a major resistance level
BUY
More Strategies
News from SeekingAlpha
11/20 Illumina, Inc. 2017 Q3 - Results - Earnings Call Slides
11/17 YOUR DAILY PHARMA SCOOP : Gilead CAR-T Potential, Egalet Surges, Aerie Launches ..
11/16 YOUR DAILY PHARMA SCOOP : A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tu..
11/15 Illumina launches new automated NGS system NextSeq 550Dx
11/09 YOUR DAILY PHARMA SCOOP : Portola Upside, Novartis Reports Positive Cosentyx Dat..
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 220 $
Spread / Average Target 2,3%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive VP-Operations, Products & Strategy
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA65.61%31 441
THERMO FISHER SCIENTIFIC INC.36.73%76 886
DANAHER20.99%65 220
INTUITIVE SURGICAL87.61%44 437
BOSTON SCIENTIFIC CORPORATION33.15%39 095
ROYAL PHILIPS14.64%37 011